A gene variant found almost exclusively in the genomes of people of African ancestry increases the risk of developing Parkinson’s disease, according to an international study of nearly 198,000 participants with this genetic background.
Verve Therapeutics, Lilly to advance gene editing programme
The collaboration will advance Verve Therapeutics’ in vivo gene editing programme targeting lipoprotein(a) to treat atherosclerotic cardiovascular disease. Credit: aodaodaodaod / Shutterstock.com. Verve Therapeutics and